Drawing for CELLGORITHM

USPTO serial 99752458

CELLGORITHM

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
LAMONT, JOHN CHRISTOPHER
Law office
TMO LAW OFFICE 123

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with CELLGORITHM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina L. Martini

Christina L. Martini Dechert LLP444 West Lake Street, Suite 2100Chicago, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
001Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; differentiated or terminal cells for research and scientific purposes; lineage specific progenitor cells for research and scientific purposes; organoids for research and scientific purposes; organoids for drug screening; multi-cell type organoid engineering; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells other than for medical use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical useACTIVE—
005Pharmaceuticals in the nature of cell therapeutics and organoid therapeutics for medical, therapeutic or clinical use; genetically or otherwise modified cells or organoids for medical or clinical use; cells or organoids which are propagated, cultivated and expanded in bioreactors for medical or clinical use; cells or organoids for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells or organoids for medical use; diagnostic preparations for medical and veterinary purposes; cell or organoid preparations for medical use in drug screening; cell or organoid preparations for genetic testing and screening for clinical and medical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells, tissue culture media, cytokines, antibodies and reagents for medical and diagnostic or clinical use; tissue culture media growth factors in the nature of cell growth, cell growth media and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells all for medical and clinical use; cell separation reagents for medical and clinical useACTIVE—
009Downloadable and recorded computer software, artificial intelligence, machine learning methods, and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software program, artificial intelligence, machine learning methods, for medical, clinical, research and biomanufacturing purposes, namely, downloadable and recorded software for conducting medical and clinical research and control laboratory biomanufacturing robots; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Aug 21, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2026DOCKASSIGNED TO EXAMINER—
Jul 30, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 8, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 8, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance